IBM Financing Cash Flow

IBM · Financing Cash Flow

IBM logo

IBM Financing Cash Flow

Latest reported-$9.43B
IBM TTM Cash from Financing (-$306.00M → -$9.43B)
High-resolution chart · PNG

IBM financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

IBM Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-9,427,000,000
-6,553,000,000
-3,829,000,000
-2,099,000,000
-1,852,000,000
-3,513,000,000
-7,079,000,000
-7,018,000,000
-7,385,000,000
-5,600,000,000
-1,769,000,000
-3,006,000,000
839,000,000
-627,000,000
-4,958,000,000
-4,798,000,000
-7,259,000,000
-6,194,000,000
-13,354,000,000
-16,955,000,000
-16,896,000,000
-15,389,000,000
-9,721,000,000
-9,103,000,000
-15,591,000,000
7,064,000,000
9,042,000,000
10,112,000,000
17,853,000,000
-5,697,000,000
-10,469,000,000
-6,783,000,000
-9,103,000,000
-7,193,000,000
-6,418,000,000
-6,786,000,000
-8,215,000,000
-10,846,000,000
-5,906,000,000
-5,967,000,000
-3,630,000,000
-2,958,000,000
-9,166,000,000
-13,517,000,000
-14,489,000,000
-14,181,000,000
-15,452,000,000
-12,766,000,000
-10,773,000,000
-11,840,000,000
-9,883,000,000
-10,661,000,000
-12,341,000,000
-12,376,000,000
-11,976,000,000
-10,995,000,000
-12,157,000,000
-13,698,000,000
-13,696,000,000
-12,745,000,000
-12,531,000,000
-11,374,000,000
-12,428,000,000
-11,775,000,000
-13,488,000,000
-13,485,000,000
-14,700,000,000
-16,364,000,000
-13,077,000,000
-13,621,000,000
-11,834,000,000
-9,585,000,000
-6,815,000,000
-5,819,000,000
-4,740,000,000
-4,422,000,000
-6,966,000,000
-7,368,000,000
-8,204,000,000
-7,405,000,000
-9,462,000,000
-7,113,000,000
-7,147,000,000
-9,590,000,000
-7,331,000,000
-8,494,000,000
-7,588,000,000
-8,169,000,000
-8,855,000,000
-8,790,000,000
-7,798,000,000
-5,804,000,000
-4,554,000,000
-4,276,000,000
-7,265,000,000
-7,892,000,000
-8,607,000,000
-8,717,000,000
-5,309,000,000
-6,381,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.